21 CFR § 230.210 - General reporting requirements for designated medical gas adverse events.

---
identifier: "/us/cfr/t21/s230.210"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 230.210 - General reporting requirements for designated medical gas adverse events."
title_number: 21
title_name: "Food and Drugs"
section_number: "230.210"
section_name: "General reporting requirements for designated medical gas adverse events."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "C"
subchapter_name: "DRUGS: GENERAL"
part_number: "230"
part_name: "CERTIFICATION AND POSTMARKETING REPORTING FOR DESIGNATED MEDICAL GASES"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 321, 331, 351, 352, 353, 355, 355a, 355f, 356, 356a, 356b, 356c, 356e, 360b, 360cc, 360ddd, 360ddd-1, 371, 374, 379e, 379k-1, 381."
regulatory_source: "89 FR 51777, June 18, 2024, unless otherwise noted."
cfr_part: "230"
---


# 230.210 General reporting requirements for designated medical gas adverse events.

(a) *Review of safety information.* Each applicant and nonapplicant must promptly review all safety information that the applicant or nonapplicant receives or otherwise obtains from any source, foreign or domestic, such as information derived from commercial marketing experience, reports in the published scientific and medical literature, unpublished scientific papers, and reports from regulatory authorities.

(b) *Safety reporting disclaimer.* (1) A report or information submitted by an applicant or nonapplicant (and any release by FDA of that report or information) under § 230.220 or § 230.230 does not necessarily reflect a conclusion by the applicant or nonapplicant or by FDA that the report or information constitutes an admission that the designated medical gas caused or contributed to an adverse effect.

(2) An applicant or nonapplicant need not admit, and may deny, that the report or information submitted under § 230.220 or § 230.230 constitutes an admission that the designated medical gas caused or contributed to an adverse effect.